Blog

Selection of the Right Partner

Key Decision For many drug developing companies, the selection of the right CDMO that will fulfill the activities from Cell Line Development to the manufacturing […]

Read more

CMC in early stage: a customer testimonial.

Thierry Bernardi, PharmaD, is CEO of BioFilm Pharma, a startup developing new antibiotics that specifically target the bacterial biofilm. Their candidates are news entities and […]

Read more

The Target Product Profile

Approximately 25% of late phase trials fail due to commercial and strategic issues. A more robustly developed Target Product Profile (TPP) could reduce this risk […]

Read more

An effective CMC Strategy

“Strategy” is defined as a course of activities designed to lead to an overall aim. Thus, the CMC regulatory compliance strategy is the course of […]

Read more

Why CMC Matters ?

What happens when no sufficient effort is put on CMC ? Starting from your research lab, where you found an interesting compound that might end […]

Read more

3Biotech’s blog reopens!

3Biotech (re)opens their blog today ! We will fill this blog weekly with our views on drug development, CMC challenges for small and big molecules, and […]

Read more

Vous avez un projet ? Prenez contact avec 3Biotech !







Adresse

3Biotech

      • Le siège :
        66 Avenue des Champs-Élysées Paris 8ème, France

     

    • Nos bureaux :
      Spaces, 126 avenue du Général Leclerc, 92100 Boulogne-Billancourt, FRANCE

Telephone : 33 (0)1 76 50 40 45

E-mail: contact@3biotech.eu
Website: www.3biotech.com